¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acute inflammation of orbit"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ulcerative inflammation
    ±Ë¾ç¿°Áõ
  • acute
    ±Þ¼º-
  • acute abdomen
    ±Þ¼ºº¹Áõ
  • acute acalculous cholecystitis
    ±Þ¼º¹«°á¼®¾µ°³(ÁÖ¸Ó´Ï)¿°, ±Þ¼º¹«°á¼®´ã³¶¿°
  • acute appendicitis
    ±Þ¼ºÃæ¼ö¿°, ±Þ¼º¸·Ã¢ÀÚ²¿¸®¿°
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • acute catarrhal laryngitis
    ±Þ¼ºÄ«Å¸¸£Èĵο°
  • acute cholecystitis
    ±Þ¼º¾µ°³(ÁÖ¸Ó´Ï)¿°, ±Þ¼º´ã³¶¿°
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • acute delusional psychosis
    ±Þ¼º¸Á»óÁ¤½Åº´
  • acute disseminated encephalitis
    ±Þ¼ºÆÄÁ¾³ú¿°
  • acute disseminated encephalomyelitis
    ±Þ¼ºÆÄÁ¾³úô¼ö¿°
  • acute epiglottitis
    ±Þ¼ºÈĵΰ³¿°
  • acute exposure
    ±Þ¼º³ëÃâ
  • acute fulminating meningococcemia
    ±Þ¼ºÀü°Ý¼ö¸·¾Ë±ÕÇ÷Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ulcerative inflammation
    ±Ë¾ç¿°Áõ
  • acute
    ±Þ¼º-
  • acute exposure
    ±Þ¼ºÇÇÆø, ±Þ¼º³ëÃâ
  • acute abdomen
    ±Þ¼ºº¹Áõ
  • acute anxiety neurosis
    ±Þ¼ººÒ¾È½Å°æÁõ
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • acute catarrhal laryngitis
    ±Þ¼ºÄ«Å¸¸£Èĵο°
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • acute delusional psychosis
    ±Þ¼º¸Á»óÁ¤½Åº´
  • acute disseminated encephalitis
    ±Þ¼ºÆÄÁ¾³ú¿°
  • acute fulminating meningococcemia
    ±Þ¼ºÀü°Ý¼ö¸·¾Ë±ÕÇ÷Áõ
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • acute idiopathic polyneuritis
    ±Þ¼ºÆ¯¹ß´Ù¹ß½Å°æ¿°, ±Þ¼ºÆ¯¹ß¿©·¯½Å°æ¿°
  • acute infectious disease
    ±Þ¼º°¨¿°º´
  • acute intermittent porphyria
    ±Þ¼º°£ÇæÆ÷¸£ÇǸ°Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acute ataxia
    ±Þ¼º ¿îµ¿½ÇÁ¶(¡­ê¡ÔÑã÷ðà).
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(¡­á¬Ð¶àõÎ¼ï½æú).
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°(¡­á¬Ð¶àõãýҮدæú).
  • acute barbiturate intoxication
    ±Þ¼º ¹Ù¸£ºñÅ»Áßµ¶.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute brain syndrome
    ±Þ¼º ³úÁõÈıº(¡­Òàñøý¦ÏØ).
  • acute bronchitis
    ±Þ¼º ±â°üÁö¿°(¡­Ñ¨Î· ò¨æú).
  • acute bulbar polioencephalitis
    ±Þ¼º ¿¬¼öȸ¹é³ú¿°(¡­æÅâÐüéÛÜÒàæú).
  • acute carditis
    ±Þ¼º ½É(Àå)¿°(¡­ãýíôæú).
  • acute catarrhal laryngitis
    ±Þ¼º īŸ¸£(¼º) Èĵο°
  • acute catarrhal tonsillitis
    ±Þ¼º īŸ¸£(¼º) Æíµµ¿°
  • acute coalescent mastoiditis
    ±Þ¼º À¶ÇÕ(¼º) À¯µ¹(±â)¿°
  • acute colitis
    ±Þ¼º°áÀå¿°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • inflammation
    ¿°Áõ
  • inflammation ³ª inflammatio
    ¿°(Áõ)(æúñø)
  • inflammation,chemical mediators
    È­ÇÐ ¸Å°³¹°Áú(ûùùÊ ØÚ˿ڪòõ)
  • inflammation,cytopathic-cytoproliferative
    ¼¼Æ÷º´º¯-¼¼Æ÷Áõ½Ä¼º(á¬øàܻܨ-á¬øàñòãÖàõ)ÀÇ
  • inflammation,exudative
    ¼º(ß¶õóàõ), »ïÃ⼺ÀÇ
  • inflammation,kinin system
    Ű´Ñ °è, kinin °è(¡­ ͧ)
  • inflammation,leukocytic exudation
    ¹éÇ÷±¸¼º »ïÃâ¹°(ÛÜúìϹàõ ¡­)
  • inflammation,lysosomal constituents
    ¸®¼Ò¼Ø(¿ëÇØ¼Òü)((éÁú°á³ô÷) à÷ÝÂ)
  • inflammation,necrotizing
    ±«»ç¼º(ÎÕÞÝàõ)
  • inflammation,plasma proteases
    Ç÷Àå ÇÁ·ÎÅ×¾ÆÁ¦(úìíì ¡­)
  • inflammation,vascular flow and caliber
    Ç÷°üÇ÷·ù(úìηúì×µ)¿Í±¸°æ(Ï¢ÌÓ)
  • inflammation,vascular permeability
    Åõ°ú¼º(úìη ÷âΦàõ)
  • interstitial inflammation
    °£Áú¼º ¿°(Áõ).(¡­ æú(ñø))
  • interstitital inflammation
    °£Áú¼º ¿°Áõ(¡­ æúñø)
  • mechanical inflammation =MI
    ±â°èÀû ¿°Áõ(¡­æúñø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DRIP delirium and drugs-restricted mobility and retention-infection, inflammation and impaction-polyuria ...
HEMRI hereditary multifocal relapsing inflammation
ICT icteric, icterus; indirect Coombs test; inflammation of connective tissue; insulin coma therapy; int...
Inflamm inflammation, inflammatory
NIP nipple; no infection present; no inflammation present
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ACS Acute Confusional State
ACS Acute Coronary Syndromes
AFP Acute Flaccid Paralysis
aGVHD Acute GVHD
AHC Acute Hemorrhagic Conjunctivitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute abdomen
    ±Þ¼º º¹Áõ
    ÀϹÝÀûÀ¸·Î º¹°­³» Àå±âÀÇ ¿°Áõ¡¤Ãµ°ø¡¤Æó»ö¡¤°æ»ö¡¤ÆÄ¿­¿¡ ÀÇÇÑ º¹ÅëÀ» ¼ö¹ÝÇÏ´Â, °©Àڱ⠹ߺ´ÇÏ´Â º¹ºÎÀÇ »óÅÂ. º¸Åë ±ä±ÞÇÑ ¿Ü°úÀû óġ¸¦ ÇÊ¿ä·Î ÇÑ´Ù. ¿¹¸¦ µé¸é, ±Þ¼º ´ã³¶¿°, ±Þ¼º Ãæ¼ö¿°, õ°øµÈ ¼ÒÈ­¼º ±Ë¾ç, °¨µ· Çã´Ï¾Æ, »óÀå°£¸· µ¿¸Æ Ç÷ÀüÁõ, ºñÀå ÆÄ¿­ µîÀÌ ÀÖ´Ù.
  • acute abdomenitis
    ±Þ¼º º¹Áõ
  • acute alcoholism
    ±Þ¼º ¾ËÄÚ¿Ã Áßµ¶, ±Þ¼º ¾ËÄÚ¿Ã Áßµ¶Áõ£©¾ËÄÝÀÇ ¼·Ãë·Î ÀÎÇØ¼­ »ýü°¡ Á¤½ÅÀû, ½ÅüÀû ¿µÇâÀ» ¹Þ°í ÁÖ·Î Àϰú¼ºÀ¸·Î ÀǽÄÀå¾Ö°¡ »ý±â´Â °Í.

    acute allergic reaction (±Þ¼º °ú¹Î¼º ¹ÝÀÀ

  • acute alveolar injury
    ±Þ¼º ÆóÆ÷ ¼Õ»ó
    ±Þ¼º È£Èí°ï¶õ ÁõÈıºÀÇ ´Ù¸¥ À̸§.
  • acute anxiety neurosis
    ±Þ¼º ºÒ¾È½Å°æÁõ
  • acute apical abscess
    ±Þ¼º Ä¡±Ù´Ü ³ó¾ç
    µ¿ÀǾî=acute alveolar abscess.
  • acute appendicitis
    ±Þ¼º Ãæ¼ö¿°
    1. Ãæ¼ö¿° ȯÀÚÀÇ 50-80%¿¡¼­ ºÐ¼®
  • acute ascending paralysis
    ±Þ¼º »óÇà ¸¶ºñ, ±Þ¼º »óÇ༺ ¸¶ºñ
  • acute ataxia
    ±Þ¼º ¿îµ¿½ÇÁ¶
    ±ÙÀ° »óÈ£ÇùÁ¶°¡ °á¿©µÇ°Å³ª ±ÙÀ°±â´ÉÀÌ ºÒ±ÔÄ¢ÇÏ¿© ¿îµ¿±â´ÉÀÌ »ó½ÇµÇ´Â °Í.
  • acute atrophic candidiasis
    ±Þ¼º À§Ã༺ ĵµð´ÙÁõ
    ±Þ¼º À§Ã༺ ĵµð´ÙÁõÀÇ º´¼Ò´Â ĵµð´Ù °¨¿°ÀÇ ¶Ç ´Ù¸¥ ÇüÅ·μ­ ÈçÇÑ °ÍÀº ¾Æ´Ï´Ù. ÀÌ º´¼Ò´Â ¹Ýµå½Ã µ¿ÀÏ ÇüÅÂÀÇ È¯ÀÚ Áï ±Þ¼º À§¸·¼º ĵµð´ÙÁõÀ¸·Î ÁøÇàµÇ±â ½¬¿î ȯÀÚ¿¡¼­ ³ªÅ¸³­´Ù. ¶Ç ±¤¹üÀ§ Ç×»ýÁ¦ ½ºÅ×·ÎÀ̵å Á¦Á¦ ¶Ç´Â ¸é¿ª ¾ïÁ¦Á¦¸¦ Åõ¿© ¹Þ´Â ȯÀÚ¿¡¼­µµ ³ªÅ¸³­´Ù. Á¶Á÷ Ç¥º»À» º¸¸é Ç¥ÃþºÎ¿¡ ¼Ò¼öÀÇ ±Õ»ç¸¦ °¡Áö´Â À§Ã༺ »óÇǰ¡ ³ªÅ¸³ª°í °íÀ¯ Ãþ¿¡¼­´Â ´ë°³ °æ¹ÌÇÑ ±Þ¼º ¿°Áõ¼º ħÀ±ÀÌ ³ªÅ¸³ª¸ç Ç÷°üÀÇ ¼ö°¡ Áõ°¡ÇÑ´Ù. ĵµð´ÙÁõ ½Ã ³ªÅ¸³ª´Â º´¼Ò´Â ´Ï½ºÅ¸Æ¾ ±¸°­ Çöʾ×À̳ª ±¸°­ Á¤Á¦·Îµµ »ç¿ëµÇ´Â ´Ï½ºÅ¸Æ¾ Á¤Á¦¸¦ »ç¿ëÇØµµ Àß Ä¡À¯µÈ´Ù.
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°
  • acute bacterial meningitis
    ±Þ¼º ¼¼±Õ¼º ³ú¸·¿°
  • acute bacterial sialadenitis
    ±Þ¼º ¼¼±Õ¼º Ÿ¾×¼±¿°
  • acute bleeding
    ±Þ¼º ÃâÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
serous inflammation An exudative inflammation in which the exudate is predominantly fluid (e.g., exuded from the blood vessels), with the protein, electrolytes, and other material contained therein; relatively few (if any) cells are observed.
(05 Mar 2000)
hyperplastic inflammation An inflammatory reaction in which the distinguishing feature is an actual increase in the number of tissue cells, especially the reticuloendothelial macrophages, in contrast to cells exuded from blood vessels; in addition, exudates of various types are likely to be observed in granulomas and other forms of proliferative inflammation, but the latter may occur without an exudate being formed (as in certain infections caused by virus).
Synonym: hyperplastic inflammation.
(05 Mar 2000)
necrotic inflammation Usually an acute inflammatory reaction in which the predominant histologic change is fairly rapid necrosis that occurs diffusely or extensively in relatively large foci throughout the affected tissue, frequently with only little or no evidence of cells in the exudate.
(05 Mar 2000)
subacute inflammation An inflammation that is intermediate in duration between that of an acute inflammation and that of a chronic inflammation, usually persisting longer than 3 or 4 weeks.
(05 Mar 2000)
suppurative inflammation An acute exudative inflammation in which the accumulation of polymorphonuclear leukocytes is sufficiently great that their enzymes cause liquefaction of the affected tissues, focally or diffusely; the purulent exudate is frequently termed pus, and consists of plasma and its constituents, end products of the enzymatic digestion of tissue, degenerated and necrotic cells and their debris, polymorphonuclear leukocytes and other white blood cells, the causal agent of the inflammation, etc.
Synonym: suppurative inflammation.
(05 Mar 2000)
degenerative inflammation A local reaction to injury, occasionally observed in the walls of blood vessels and in parenchymal cells of various organs in reacting to certain chemicals, viruses, and other intracellular agents; the response is characterised by degenerative changes in the cytoplasm and nucleus, frequently resulting in necrosis, but exudation (if any) is ordinarily observed only in the wall of the affected vessel, or in the interstices immediately adjacent to the affected vessel or parenchymal cells.
Synonym: degenerative inflammation.
(05 Mar 2000)
immune inflammation See: allergic reaction.
(05 Mar 2000)
inflammation <pathology> A localised protective response elicited by injury or destruction of tissues, which serves to destroy, dilute or wall off (sequester) both the injurious agent and the injured tissue.
It is characterised in the acute form by the classical signs of pain (dolor), heat (calor), redness (rubor), swelling (tumour) and loss of function (functio laesa).
Histologically, it involves a complex series of events, including dilatation of arterioles, capillaries and venules, with increased permeability and blood flow, exudation of fluids, including plasma proteins and leucocytic migration into the inflammatory focus.
Origin: L. Inflammatio, inflammare = to set on fire
(11 Jun 1998)
inflammation: gallium imaging <radiology> Pathophysiology: leakage of protein-bound Ga-67 into extracellular space secondary to increased capillary permeability, Ga-67 is preferentially bound to nonviable PMNs and macrophages, leukocyte incorporation (rich in lactoferrin), bacterial uptake (siderophores), inflammtory tissue stimulates lactoferrin production for chronic abdominal inflammation: 67% sensitivity; 64% specificity; 13% false negatives; 5% false positive, dose: 5 mCi; imaging: 24, 48, 72 hours, diffuse uptake in peritonitis, localised uptake in acute pyogenic abscess, phlegmon, acute cholecystitis, acute pancreatitis, acute gastritis, diverticulitis, inflammatory bowel disease, surgical wound, pyelonephritis, perinephric abscess see: gallium indications, gallium vs. Indium
(12 Dec 1998)
inflammation mediators The endogenous compounds that mediate inflammation (autacoids) and related exogenous compounds including the synthetic prostaglandins (prostaglandins, synthetic).
(12 Dec 1998)
interstitial inflammation Inflammation in which the inflammatory reaction occurs chiefly in the supportive fibrous connective tissue or stroma of an organ.
(05 Mar 2000)
exudative inflammation Inflammation in which the conspicuous or distinguishing feature is an exudate, which may be chiefly serous, serofibrinous, fibrinous, or mucous (e.g., relatively few cells are present), or may be characterised by relatively large numbers of neutrophils, eosinophils, lymphocytes, monocytes, or plasma cells, frequently with one or two types being predominant; it occurs not only as a separate and distinct pathologic process, but also frequently as a part of certain granulomatous inflammation's.
(05 Mar 2000)
fibrinopurulent inflammation A purulent inflammation in which the exudate contains an unusually large amount of fibrin; also, a fibrinous or serofibrinous inflammation in which the accumulation of large numbers of polymorphonuclear leukocytes results in liquefactive necrosis of tissue and the formation of pus with a relatively large quantity of fibrin.
(05 Mar 2000)
fibrinous inflammation An exudative inflammation in which there is a disproportionately large amount of fibrin.
(05 Mar 2000)
fibroid inflammation A form of chronic inflammation or repeated episodes of acute inflammation in which the continued or recurrent proliferation of fibroblasts results in the formation of fibrous tissue that eventually contracts and leads to compression and atrophy of parenchymal tissue.
Synonym: fibroid inflammation.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á